“Evaluation of UHRF1 and P16INK4A Expression Levels in Newly Diagnosed AML Patients”. Biomedical Research and Therapy 5, no. 9 (September 27, 2018): 2658–2663. Accessed November 15, 2024. https://preservation.bmrat.org/index.php/BMRAT/article/view/475.